BACKGROUND: Corticosteroids are commonly administered perioperatively in pediatric cardiac surgery to reduce cardiopulmonary bypass induced inflammation. However, their effects on outcomes and potential for adverse events are not well defined. METHODS: A review was undertaken of cardiac operations between September 2004 and December 2007 carrying a comprehensive Aristotle score 10 or greater. A nonrandomized comparison was undertaken comparing those patients having received intraoperative methylprednisolone at anesthesia induction or in the bypass circuit prime with those who did not. To account for nonrandom assignment of steroid use, a propensity model was created to establish each patient's probability of having received steroids (∼150 variables evaluated, 17 in final model, c-stat 0.94, p < 0.001). Associations between postoperative outcomes and intraoperative steroid use were modeled in multivariable linear regression models adjusted for propensity score and relevant surgical characteristics. RESULTS: In 221 identified cases, 134 (61%) patients received intraoperative steroids; of these, 44 (33%) also received preoperative doses. In propensity-adjusted regression models, intraoperative steroid use was associated with lower chest tube volume loss in the first 24 postoperative hours (-5.3 mL/kg, p < 0.001), and shorter durations of stay in intensive care (-2.3 days, p < 0.001) and hospital (-4.1 days, p < 0.001). Use of an additional preoperative dose resulted in further improvements, especially a reduction in duration of mechanical ventilation (-1.7 days versus no steroids, -1.2 days versus intraoperative steroids only, p = 0.002). Steroids were not associated with increased postoperative lactate, creatinine, or glucose levels, or odds of infection. CONCLUSIONS: Intraoperative steroid use is associated with improved postoperative outcomes for children undergoing high-risk cardiac surgery, with further benefits associated with a preoperative dose.
BACKGROUND: Corticosteroids are commonly administered perioperatively in pediatric cardiac surgery to reduce cardiopulmonary bypass induced inflammation. However, their effects on outcomes and potential for adverse events are not well defined. METHODS: A review was undertaken of cardiac operations between September 2004 and December 2007 carrying a comprehensive Aristotle score 10 or greater. A nonrandomized comparison was undertaken comparing those patients having received intraoperative methylprednisolone at anesthesia induction or in the bypass circuit prime with those who did not. To account for nonrandom assignment of steroid use, a propensity model was created to establish each patient's probability of having received steroids (∼150 variables evaluated, 17 in final model, c-stat 0.94, p < 0.001). Associations between postoperative outcomes and intraoperative steroid use were modeled in multivariable linear regression models adjusted for propensity score and relevant surgical characteristics. RESULTS: In 221 identified cases, 134 (61%) patients received intraoperative steroids; of these, 44 (33%) also received preoperative doses. In propensity-adjusted regression models, intraoperative steroid use was associated with lower chest tube volume loss in the first 24 postoperative hours (-5.3 mL/kg, p < 0.001), and shorter durations of stay in intensive care (-2.3 days, p < 0.001) and hospital (-4.1 days, p < 0.001). Use of an additional preoperative dose resulted in further improvements, especially a reduction in duration of mechanical ventilation (-1.7 days versus no steroids, -1.2 days versus intraoperative steroids only, p = 0.002). Steroids were not associated with increased postoperative lactate, creatinine, or glucose levels, or odds of infection. CONCLUSIONS: Intraoperative steroid use is associated with improved postoperative outcomes for children undergoing high-risk cardiac surgery, with further benefits associated with a preoperative dose.
Authors: Sara K Pasquali; Jennifer S Li; Xia He; Marshall L Jacobs; Sean M O'Brien; Matthew Hall; Robert D B Jaquiss; Karl F Welke; Eric D Peterson; Samir S Shah; J William Gaynor; Jeffrey P Jacobs Journal: Pediatrics Date: 2012-01-23 Impact factor: 7.124
Authors: H Hakan Poyrazoğlu; Zeynel Duman; Şerafettin Demir; M Kemal Avşar; Atakan Atalay; Bahattin Çiftçi; İhsan Bayraktar; Funda Tor Journal: Balkan Med J Date: 2016-03-01 Impact factor: 2.021
Authors: James M Meza; Edward J Hickey; Eugene H Blackstone; Robert D B Jaquiss; Brett R Anderson; William G Williams; Sally Cai; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle Journal: Circulation Date: 2017-07-07 Impact factor: 29.690
Authors: Eric M Graham; Reneé H Martin; Jason R Buckley; Sinai C Zyblewski; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Marc Hassid; Andrew M Atz Journal: J Am Coll Cardiol Date: 2019-08-06 Impact factor: 24.094
Authors: Rebecca F Turcotte; Ava Brozovich; Rozelle Corda; Ryan T Demmer; Katherine V Biagas; Diane Mangino; Lisa Covington; Anne Ferris; Brian Thumm; Emile Bacha; Art Smerling; Lisa Saiman Journal: Pediatr Cardiol Date: 2014-07-05 Impact factor: 1.655
Authors: Eric M Graham; Andrew M Atz; Kimberly E McHugh; Ryan J Butts; Nathaniel L Baker; Robert E Stroud; Scott T Reeves; Scott M Bradley; Francis X McGowan; Francis G Spinale Journal: J Thorac Cardiovasc Surg Date: 2013-07-16 Impact factor: 5.209